Brainsway Dtms denied for missing prior authorization by Humana?

Humana's specific coverage criteria for brainsway dtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for BrainsWay Deep TMS

Humana requires prior authorization (PA) for BrainsWay Deep TMS before the service is rendered. A denial at this stage means either the PA was not obtained in advance, the submitted documentation did not satisfy Humana's clinical criteria, or the request was submitted for an indication or setting not covered by the plan. PA denials are among the most appealable denial types because they are often resolved by supplying more complete clinical documentation.

If treatment has already been received without a PA, you are pursuing a retrospective review—the same appeal rights apply, though the administrative posture differs slightly.

## Federal Appeal Framework

• ACA §2719 / External Review: Available within approximately 4 months (180 days) of the denial notice for most non-grandfathered plans. An expedited external review (typically 72-hour turnaround) is available when your condition is urgent or you are currently receiving the treatment.
• ERISA §503 (employer-sponsored plans): Requires Humana to provide the specific criteria not met, a full-and-fair internal review, and the right to submit supplemental clinical evidence.
• Urgent/concurrent care protections: If you are mid-course in a treatment series, request expedited review immediately and note the clinical harm of interruption.

## Appeal Process and Timeline

1. Request the PA denial letter in full — Humana must specify which clinical criteria were not satisfied. If the denial is vague, request the complete clinical review rationale in writing. 2. Assemble the documentation gap — compare the criteria Humana cited against what was originally submitted and identify what is missing. 3. Internal appeal — submit a complete package within Humana's appeal deadline. Standard review is up to 30 days; urgent/expedited is 72 hours. 4. External review — if the internal appeal is denied, request independent external review through the process described in your denial letter.

## Documentation to Gather

• Confirmed diagnosis: Comprehensive chart notes with diagnostic coding and clinical assessment.
• Prior treatment history with dates and outcomes: A chronological list of all prior treatments for this condition, including medications, therapy modalities, and any other interventions—with documented response or reason for discontinuation.
• Clinical severity: Validated assessment scales, functional-impairment documentation, and clinician notes from the chart.
• Prescriber medical-necessity letter: A detailed letter addressed to Humana's PA criteria, mapping each criterion to a specific chart finding.
• Ordering provider credentials: Confirm the prescriber's specialty and qualifications meet any Humana requirements.

## Criteria-Mapping Structure

Obtain Humana's current published coverage/medical policy for Deep TMS. Map each requirement to chart evidence:

| Humana PA Criterion | Supporting Chart Evidence | |---|---| | Confirmed diagnosis per policy definition | [Chart documentation] | | Required prior treatment failures | [Treatment list with dates and outcomes] | | Severity criteria met | [Assessment scores and clinical notes] | | Ordering clinician qualifications | [Specialty and credentials] | | Setting/facility requirements | [Proposed treatment site information] |

Submitting a complete, criterion-by-criterion package on the first appeal significantly increases the likelihood of approval without needing to proceed to external review.